Lipid peroxidation and antioxidant status in experimental diabetes

Clinica Chimica Acta

Volumn 284, Issue 1, 1999, Pages 31-43

  Feillet Coudray, C ^a   Rock, E ^a   Coudray, C ^a   Grzelkowska, K ^a   Azais Braesco, V ^a   Dardevet, D ^a   Mazur, A ^a  

^a CRNH AUVERGNE   (France)

Author keywords

Antioxidant status; Isoprostane; Streptozotocin diabetic rat; Susceptibility to peroxidation; Vitamin E

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ISOPROSTANE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET; ERYTHROCYTE; HEMOLYSIS; LIPID PEROXIDATION; LIVER HOMOGENATE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VITAMIN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; ARACHIDONIC ACID; DIABETES MELLITUS, EXPERIMENTAL; DINOPROST; HEMOLYSIS; LIPID PEROXIDATION; LIVER; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; STREPTOZOCIN; TRIGLYCERIDES;

ANIMALIA;

EID: 0032782476     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00046-7     Document Type: Article

References (41)

1. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. 2nd ed :1989;Clarendon Press, Oxford.
2. Mullarkey C.J., Edelstein D., Brownlee L. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun. 173:1990;932-939.
3. Baynes J.W. Role of oxidative stress in the development of complications in diabetes. Diabetes. 40:1991;405-412.
4. Strain J.J. Disturbances of micronutriment and antioxidant status in diabetes. Proc Nutr Soc. 50:1991;591-604.
5. McLennan S.V., Heffernen S., Wright L., et al. Changes in hepatic glutathione metabolism in diabetes. Diabetes. 40:1991;344-348.
6. Jennings P.B., Chirico S., Jones A.F., Lunec J., Barnett A.H. Vitamin C metabolites and microangiopathy in diabetes mellitus. Diab Res. 6:1987;151-154.
7. Young I.S., Torney J.J., Trimble E.R. The effect of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat. Free Rad Biol Med. 13:1992;41-46.
8. Velazques B., Winocour P.H., Kesteven P., Alberti K.G.M.M., Lakeer M.F. Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med. 8:1991;752-758.
9. MacRury S.M., Gordon D., Wilson R., et al. A comparison of different methods of assessing free radical diabetes and peripheral vascular disease. Diabet Med. 10:1993;331-335.
10. Griesmacher A., KinderHauser M., Andert S., et al. Enhanced serum levels of thiobarbituric acid-reactive substances in diabetes mellitus. Am J Med. 98:1995;469-475.
11. Niskanen L.K., Salonen J.T., Nyssonen K., Uusitupa M.I.J. Plasma lipid peroxidation and hyperglycemia: a connection through hyperinsulinaemia? Diabet Med. 12:1995;802-808.
12. Sundaram R.K., Bhaskar A., Vijayalingam S., Viswanatthan M., Moha R., Shaninugasundaram K.R. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci. 90:1996;255-260.
13. Kakkar R., Mantha S.V., Radhi J., Prasad K., Kalra J. Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. J Clin Sci. 94:1998;623-632.
14. Nassir F., Mazur A., Giannoni F., Gueux B., Davidson N.O., Rayssiguier Y. Magnesium deficiency modulates hepatic lipogenesis and apolipoprotein gene expression in the rat. Biochim Biophys Acta. 1257:1995;125-132.
15. Gueux B., Azais-Braesco V., Bussière L., Grolier P., Mazur A., Rayssiguier Y. Effect of magnesium deficiency on triacylglycerol-rich lipoprotein and tissue susceptibility to peroxidation in relation to vitamin E content. J Nutr. 126:1996;2550-2556.
16. Mancini G., Vaerman J.P., Carbonera A.O., Heremans I.F. Protides of the biological fluids. XI Colloquium, Bruges, 1963 :1964;Elsevier, Amsterdam.
17. Olikawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:1979;351-358.
18. Pryor W.A., Miki M., Das B., Church D.F. The mixture of aldehydes and hydrogen peroxide produced in the ozonation of dioleoyl phosphatidyl choline causes hemolysis of human red blood cells. Chem Biol Interaction. 79:1991;41-52.
19. Whitehead T.P., Thorpe G.H.G., Maxwell S.R.I. Enhanced chemiluminescent assay for antioxidant-capacity in biological fluids. Anal Chim Acta. 266:1992;265-277.
20. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci. 84:1993;407-412.
21. Morrow J.D., Awad J.A., Boss H.J., Blair I.A., Roberts L.J. Non cyclo-oxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA. 89:1992;10721-10725.
22. Grzelkowska K., Dardevet D., Balage M., Grizard J. Involvement of rapamycin-sensitive pathway in the insulin regulation of muscle protein synthesis in streptozotocin-diabetic rats. J Endocrinol. 160:1999;137-145.
23. Young IS, Tate S, Lightbody JH, McMaster, Trimble BR. The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Rad Biol Med 1995;18:833-840.
24. Valkonen M., Kuusi T. Spectrophotometric assay for total peroxyl radical-trapping antioxidant potential in human serum. J Lipid Res. 38:1997;823-833.
25. Rice-Evans C., Miller N.J. Total antioxidant status in plasma and body fluids. Meth Enzymol. 234:1994;279-293.
26. Halliwell B., Gutteridge J. The definition and measurements of antioxidants in biological systems. Free Rad Biol Med. 18:1995;125-126.
27. Asayama K., Nakane T., Uchida N., Hayashibe H., Dobashi K., Nakazawa S. Serum antioxidant status in streptozotocin-induced diabetic rat. Horm Metab Res. 26:1994;313-315.
28. Matkovics B., Varga S.I., Szabo H., Witas H. The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metabol Res. 17:1982;77-79.
29. Kaji H., Kurasake M., Ito K., et al. Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type II (non-insulin-dependent) diabetic women. Klin Wochenschr. 63:1985;765-768.
30. Tsuchida M., Miura T., Mizutani K., Aibara K. Fluorescent substances in mouse and human sera as a parameter of in vivo lipid peroxidation. Biochim Biophys Acta. 834:1985;196-204.
31. Dohi T., Kawamura K., Morita K., Okomato H., Tsujimoto A. Alterations of the plasma selenium concentration and the activities of tissue peroxide metabolism enzymes in streptozotocin-induced diabetic rats. Horm Metab Res. 20:1988;671-675.
32. Uzel N., Sivas A., Uysal M., Oz H. Erythrocyte lipid peroxidation and glutathione peroxide activities in patients with diabetes mellitus. Horm Metab Res. 19:1987;89-90.
33. Miller F.N., Saari J.T., Alsip N.L., Schuschkle D.A. The microphotohemolytic response of erythrocytes is altered by streptozotocin-induced diabetes and copper deficiency in rats. Life Sci. 56:1995;735-745.
34. Morrow I.D., Hill K.H., Burk R.F., Nammour T.M., Badr K.F., Jackson Roberts II L. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 87:1990;9383-9387.
35. Lynch S.M., Morrow J.D., Jackson Roberts II L., Frei B. Formation of a non-cyclooxygenase derived prostanoids in plasma and low density lipoprotein exposed to oxidative stress in vivo. J Clin Invest. 93:1994;998-1004.
36. Pitkanen O.M., Martin M., Hallman M., Akerblom H.K., Sariola H., Andersson S.M. Free radical activity during development of insulin-dependent diabetes mellitus in the rat. Life Sci. 50:1992;335-339.
37. Gopaul N.K., Anggard B.B., Mallet A.I., Betteridge D., Wolff S.P., Nourooz-Zadeh J. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368:1995;225-229.
38. Wang Z., Ciabattoni G., Creminon C., et al. Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther. 275:1995;94-100.
39. Bachi A., Bianchi R., Brambilla R., Milano W., Fanelli R., Chiabrando C. In vivo formation of 8-epi-PGF2 alpha vs prostanoids in STZ diabetic rats (abstract). Diabetes. 46:(Suppl 1):1997;0912.
40. Palmer A.M., Thomas C.R., Gopaul N., et al. Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocindiabetic rat. Diabetologia. 41:1998;148-156.
41. Sukalski K.A., Pinto K.A., Berntson J.L. Decreased susceptibility of liver mitochondria from diabetic rats to oxidative damage and associated increase in alpha-tocopherol. Free Rad Biol Med. 14:1993;57-65.